KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Emergent BioSolutions (EBS) Curent Deferred Tax Liability: 2013-2014

Historic Curent Deferred Tax Liability for Emergent BioSolutions (EBS) over the last 1 years, with Sep 2014 value amounting to $88,000.

  • Emergent BioSolutions' Curent Deferred Tax Liability was N/A to $88,000 in Q3 2014 from the same period last year, while for Sep 2014 it was $88,000, marking a year-over-year change of. This contributed to the annual value of $88,000 for FY2013, which is N/A change from last year.
  • Emergent BioSolutions' Curent Deferred Tax Liability amounted to $88,000 in Q3 2014, which was down 0.00% from $88,000 recorded in Q2 2014.
  • Over the past 5 years, Emergent BioSolutions' Curent Deferred Tax Liability peaked at $88,000 during Q4 2013, and registered a low of $88,000 during Q4 2013.
  • Moreover, its 2-year median value for Curent Deferred Tax Liability was $88,000 (2014), whereas its average is $88,000.